FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751567920> ?p ?o ?g. }

• W2751567920 abstract "Using propensity score matching method (PSM) to evaluate the feasibility and clinical outcomes of simultaneous modulated accelerated radiation therapy (SMART) using helical tomotherapy (HT) in patients with nasopharyngeal carcinoma (NPC).Between August 2007 and January 2016, 381 newly diagnosed NPC patients using HT were enrolled in pre-PSM cohort, including 161 cases in a prospective phase II study (P67.5 study, with a prescription dose of 67.5Gy in 30 fractions to the primary tumour and positive lymph nodes) and 220 cases in a retrospective study (P70 study, with a prescription dose of 70Gy in 33 fractions to the primary tumour and positive lymph nodes). Acute and late toxicities were assessed according to the established RTOG/EORTC criteria and Common Terminology Criteria for Adverse Events (CTCAE) V 3.0. Survival rate were assessed with Kaplan-Meier method, log-rank test and Cox regression.After matching, 148 sub-pairs of 296 patients were generated in post-PSM cohort. The incidence of grade 3-4 leukopenia, thrombocytopenia and anemia in the P67.5 group was significantly higher than in the P70 study, but no significant different was found in other acute toxicities or late toxicities between the two groups. The median follow-up was 33 months in the P67.5 and P70 group, ranging 12-54 months and 6-58 months, respectively. No significant differences in 3-year local-regional recurrence free survival (LRRFS), distant metastasis-free survival (DMFS), disease free survival (DFS) and overall survival (OS) were observed between the 2 groups. Univariate analysis showed that age, T stage, clinical stage were the main factors effecting survival. Cox proportional hazards model showed that 67.5Gy/30F pattern seemed superior in 3-year OS (HR = 0.476, 95% CI: 0.236-0.957).Through increasing fraction dose and shortening treatment time, the P67.5 study achieved excellent short-term outcomes and potential clinical benefits, with acceptable acute and late toxicities.The trial was registered at Chinese Clinical Trial Registry on 5 July 2014 with a registration code of ChiCTRONC-14,004,895." @default.
• W2751567920 created "2017-09-15" @default.
• W2751567920 creator A5006263091 @default.
• W2751567920 creator A5009096811 @default.
• W2751567920 creator A5024873810 @default.
• W2751567920 creator A5029203166 @default.
• W2751567920 creator A5039104880 @default.
• W2751567920 creator A5044976422 @default.
• W2751567920 creator A5048379858 @default.
• W2751567920 creator A5062045949 @default.
• W2751567920 creator A5067305134 @default.
• W2751567920 creator A5073221601 @default.
• W2751567920 date "2017-08-29" @default.
• W2751567920 modified "2023-10-16" @default.
• W2751567920 title "Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas" @default.
• W2751567920 cites W1492772022 @default.
• W2751567920 cites W1525010474 @default.
• W2751567920 cites W1985487681 @default.
• W2751567920 cites W1987104299 @default.
• W2751567920 cites W2010544209 @default.
• W2751567920 cites W2016681837 @default.
• W2751567920 cites W2051061475 @default.
• W2751567920 cites W2055787075 @default.
• W2751567920 cites W2059775855 @default.
• W2751567920 cites W2060875961 @default.
• W2751567920 cites W2066497510 @default.
• W2751567920 cites W2069410394 @default.
• W2751567920 cites W2078682598 @default.
• W2751567920 cites W2095617994 @default.
• W2751567920 cites W2102004034 @default.
• W2751567920 cites W2103373618 @default.
• W2751567920 cites W2105150213 @default.
• W2751567920 cites W2109754498 @default.
• W2751567920 cites W2113470349 @default.
• W2751567920 cites W2118597156 @default.
• W2751567920 cites W2129299671 @default.
• W2751567920 cites W2134393828 @default.
• W2751567920 cites W2149057361 @default.
• W2751567920 cites W2153207593 @default.
• W2751567920 cites W2158460222 @default.
• W2751567920 cites W2158776902 @default.
• W2751567920 cites W2160982012 @default.
• W2751567920 cites W2166243031 @default.
• W2751567920 cites W2223336507 @default.
• W2751567920 cites W2240014735 @default.
• W2751567920 cites W2343172868 @default.
• W2751567920 cites W2375361509 @default.
• W2751567920 cites W2406683325 @default.
• W2751567920 cites W2526747727 @default.
• W2751567920 cites W306194270 @default.
• W2751567920 cites W4230305820 @default.
• W2751567920 cites W4238162912 @default.
• W2751567920 doi "https://doi.org/10.1186/s12885-017-3581-1" @default.
• W2751567920 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5575876" @default.
• W2751567920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28851315" @default.
• W2751567920 hasPublicationYear "2017" @default.
• W2751567920 type Work @default.
• W2751567920 sameAs 2751567920 @default.
• W2751567920 citedByCount "3" @default.
• W2751567920 countsByYear W27515679202020 @default.
• W2751567920 countsByYear W27515679202021 @default.
• W2751567920 countsByYear W27515679202022 @default.
• W2751567920 crossrefType "journal-article" @default.
• W2751567920 hasAuthorship W2751567920A5006263091 @default.
• W2751567920 hasAuthorship W2751567920A5009096811 @default.
• W2751567920 hasAuthorship W2751567920A5024873810 @default.
• W2751567920 hasAuthorship W2751567920A5029203166 @default.
• W2751567920 hasAuthorship W2751567920A5039104880 @default.
• W2751567920 hasAuthorship W2751567920A5044976422 @default.
• W2751567920 hasAuthorship W2751567920A5048379858 @default.
• W2751567920 hasAuthorship W2751567920A5062045949 @default.
• W2751567920 hasAuthorship W2751567920A5067305134 @default.
• W2751567920 hasAuthorship W2751567920A5073221601 @default.
• W2751567920 hasBestOaLocation W27515679201 @default.
• W2751567920 hasConcept C126322002 @default.
• W2751567920 hasConcept C141071460 @default.
• W2751567920 hasConcept C143998085 @default.
• W2751567920 hasConcept C167135981 @default.
• W2751567920 hasConcept C17923572 @default.
• W2751567920 hasConcept C2776713427 @default.
• W2751567920 hasConcept C2777793932 @default.
• W2751567920 hasConcept C2778997737 @default.
• W2751567920 hasConcept C50382708 @default.
• W2751567920 hasConcept C509974204 @default.
• W2751567920 hasConcept C71924100 @default.
• W2751567920 hasConceptScore W2751567920C126322002 @default.
• W2751567920 hasConceptScore W2751567920C141071460 @default.
• W2751567920 hasConceptScore W2751567920C143998085 @default.
• W2751567920 hasConceptScore W2751567920C167135981 @default.
• W2751567920 hasConceptScore W2751567920C17923572 @default.
• W2751567920 hasConceptScore W2751567920C2776713427 @default.
• W2751567920 hasConceptScore W2751567920C2777793932 @default.
• W2751567920 hasConceptScore W2751567920C2778997737 @default.
• W2751567920 hasConceptScore W2751567920C50382708 @default.
• W2751567920 hasConceptScore W2751567920C509974204 @default.
• W2751567920 hasConceptScore W2751567920C71924100 @default.
• W2751567920 hasIssue "1" @default.
• W2751567920 hasLocation W27515679201 @default.
• W2751567920 hasLocation W27515679202 @default.
• W2751567920 hasLocation W27515679203 @default.

• next